Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Non-Current Assets (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Non-Current Assets for 14 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets changed 0.0% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $1.3 million for FY2025, 0.0% changed from the prior year.
  • Non-Current Assets hit $1.3 million in Q4 2025 for STRATA Skin Sciences, up from $1.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $36.0 million in Q1 2022 to a low of $600000.0 in Q4 2022.
  • Historically, Non-Current Assets has averaged $17.7 million across 5 years, with a median of $22.6 million in 2021.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 100.0% in 2021 and later tumbled 95.38% in 2025.
  • Year by year, Non-Current Assets stood at $1.0 million in 2021, then crashed by 40.0% to $600000.0 in 2022, then skyrocketed by 33.33% to $800000.0 in 2023, then skyrocketed by 62.5% to $1.3 million in 2024, then changed by 0.0% to $1.3 million in 2025.
  • Business Quant data shows Non-Current Assets for SSKN at $1.3 million in Q4 2025, $1.2 million in Q3 2025, and $1.2 million in Q2 2025.